Journal of Urologic Oncology

Clinical Significance of Rab27a as a Urinary Biomarker in Patients With Bladder Cancer: Ja Yoon Ku, Md Nazmul Huda, Eu Chang Hwang, Chan Ho Lee, Kyung Hwan Kim, Dong Deuk Kwon, Hong Koo Ha; Journal of Urologic Oncology. 2023;21(3):277-277. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.err.kjuo.2022.20.1.52
Corrects: 2022;20(1):52; Full text PubReader ePub PDF

Contemporary Management of Small Renal Masses by Urologic Oncologists: A 2022 Korean Renal Cancer Study Group Practice Pattern Survey: Joongwon Choi, Cheryn Song, Jungyo Suh, Minyong Kang, Chang Il Choi, Hyeong Dong Yuk, Chan Ho Lee, Jung Kwon Kim, Jung Ki Jo, Won Sik Ham, Eu Chang Hwang, Chang Wook Jeong, Young Hwii Ko, Jae Young Park, Seong Il Seo, Byung Kwan Park, Jinsoo Chung, Cheol Kwak, Sung-Hoo Hong; Journal of Urologic Oncology. 2023;21(1):59-69. Published online March 31, 2023; DOI: https://doi.org/10.22465/juo.234600120006
Cited By 1; Full text PubReader ePub PDF

A Survey on the Quality of Life of Prostate Cancer Patients in Korean Prostate Cancer Patients Association: Yun-Sok Ha, Kwang Taek Kim, Wook Nam, Hongzoo Park, Sangjun Yoo, Chan Ho Lee, Ho Seok Chung, Woo Suk Choi, Jiyoun Kim, Jaeeun Shin, Jeong Hyun Kim, Cheol Kwak; Korean J Urol Oncol. 2022;20(4):265-272. Published online November 30, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.4.265
Cited By 1; Full text PubReader ePub PDF Supplementary Material

2021 Consensus Statements on the Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma From the Korean Renal Cancer Study Group (KRoCS): Chan Ho Lee, Minyong Kang, Cheol Kwak, Sung Han Kim, Jung Kwon Kim, Jae Young Park, Seong Il Seo, Ill Young Seo, Jungyo Suh, Wan Song, Cheryn Song, Hyeong Dong Yuk, Sangchul Lee, Hyung Ho Lee, Jinsoo Chung, Chang Wook Jeong, Jung Ki Jo, Chang Il Choi, Seol Ho Choo, Jun Hyun Han, Eu Chang Hwang, Miso Kim, Chan Kim, Seock Hwan Choi, Sung-Hoo Hong; Korean J Urol Oncol. 2022;20(3):151-162. Published online August 25, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.3.151
Cited By 1; Full text PubReader ePub PDF

Clinical Significance of Rab27a as a Urinary Biomarker in Patients With Bladder Cancer: Ja Yoon Ku, Eu Chang Hwang, Chan Ho Lee, Kyung Hwan Kim, Dong Deuk Kwon, Hong Koo Ha; Korean J Urol Oncol. 2022;20(1):52-58. Published online February 24, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.1.52
Correction in: 2023;21(3):277; Full text PubReader ePub PDF

Investigation of Information Acquisition Channel for Prostate Cancer High-Risk Group: Yun-Sok Ha, Kwang Taek Kim, Wook Nam, Hongzoo Park, Sangjun Yoo, Chan Ho Lee, Ho Seok Chung, Woo Suk Choi, Jiyoun Kim, Jaeeun Shin, Jeong Hyun Kim, Cheol Kwak; Korean J Urol Oncol. 2021;19(3):174-182. Published online August 31, 2021; DOI: https://doi.org/10.22465/kjuo.2021.19.3.174
Cited By 1; Full text PubReader ePub PDF Supplementary Material

6,025	New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
5,499	The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer
5,006	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
4,841	Complex Epidemiology of Prostate Cancer in Asian Countries
4,692	The Present and Future of Intravesical Therapy in Bladder Cancer

Cited By 9	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 4	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
Cited By 4	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 3	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By 2	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use

Search